2021 Scientific Sessions

Dual and Triple Therapy in the PCI Patient: A Moving Target

Welcoming Remarks
Deepak L. Bhatt, M.D., M.P.H., MSCAI, Brigham And Women's Hospital
View Recording
A Genotype-Guided Strategy for P2Y12 Inhibitors in PCI
Richard Gumina, MD, PhD, The Ohio State University College of Medicine, Columbus, OH
View Recording
Duration of Anti-Platelet Therapy for the Left Main Stent
Deepak L. Bhatt, M.D., M.P.H., MSCAI, Mount Sinai Health System, Scarsdale, NY
View Recording Download Slides
Can Short DAPT Be Applied to the Patient With an Acute Coronary Syndrome?
Roxana Mehran, M.D., MSCAI, Icahn School of Medicine at Mount Sinai, New York, NY
View Recording Download Slides
Aspirin vs. P2Y12 Inhibitor for Long-Term Therapy Upon Completion of DAPT Post-PCI
Dominick J. Angiolillo, M.D., FSCAI, UF Health Jacksonville, Jacksonville, FL
View Recording
Anti-Platelet Therapy Post-PCI in Patients on an Oral Anti-coagulant: Too Much or Too Little?
Dharam J. Kumbhani, M.D., FSCAI, University of Texas Southwestern, Dallas, TX
View Recording
Discussion
View Recording
See more of: Cath Lab Boot Camp
<< Previous Session | Next Session >>